Health
Inhibition of Meprin Β enzyme can trigger the development of Alzheimer’s disease, cancer – News-Medical.Net
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma…
Researchers at Johannes Gutenberg University Mainz (JGU) in Germany and the Institute of Molecular Biology of Barcelona in Spain have discovered how the blood plasma protein fetuin-B binds to the enzyme meprin β and used a computer model to visualize their findings.
These results could lead to the development of new drugs to treat serious diseases such as Alzheimer’s and cancer. Meprin β releases proteins from cell membranes, thus controlling important physiological functions in the human body.
…
-
General24 hours agoTyler Wright soaks up Bells Beach return as poor conditions at Rip Curl Pro sees men’s opening round called off
-
General23 hours agoTruck driver charged with causing death by dangerous driving after highway crash
-
Noosa News22 hours agoGyrocopter pilot injured in crash-landing on K’Gari, north of Brisbane
-
Noosa News12 hours agoRevealed: 75 Qld suburbs you could afford to buy in if lending standards drop